Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
33
CC Quote, Financials, Valuation and Earnings
Last price:
$13.66
Seasonality move
:
8.35%
Day range:
$12.71 - $13.31
52-week range:
$9.13 - $25.38
Dividend yield:
6.32%
P/E ratio:
69.74x
P/S ratio:
0.34x
P/B ratio:
3.43x
Volume:
3.1M
Avg. volume:
4.7M
1-year change:
-46.98%
Market cap:
$2B
Revenue:
$5.8B
EPS (TTM):
$0.19
Earnings Data
Next earnings date for CC
Aug 01
2025
Most recent earnings per share
-$0.03
Missed by $0.23
(May 6/2025)
Consensus Estimate
$0.20
(May 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CC Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $1.5B | -- | -- | $0.51 | -- |
| 08/01/2025 | Q2 | $1.6B | -- | -- | $0.46 | -- |
| 05/06/2025 | Q1 | $1.4B | $1.4B | -$0.03 | $0.20 | -$0.23 |
| 02/18/2025 | Q4 | $1.4B | $1.4B | -$0.06 | $0.16 | -$0.22 |
| 11/04/2024 | Q3 | $1.4B | $1.5B | -$0.18 | $0.28 | -$0.46 |
| 08/01/2024 | Q2 | $1.5B | $1.5B | $0.46 | $0.58 | -$0.12 |
| 04/30/2024 | Q1 | $1.4B | $1.4B | $0.34 | $0.17 | $0.17 |
| 03/28/2024 | Q4 | $1.3B | $1.4B | -$0.13 | $0.24 | -$0.37 |
| 10/26/2023 | Q3 | -- | -- | $0.13 | $0.69 | -$0.56 |
| 07/27/2023 | Q2 | -- | -- | -$2.52 | $1.07 | -$3.59 |
| 04/27/2023 | Q1 | -- | -- | $0.96 | $0.51 | $0.45 |
| 02/09/2023 | Q4 | -- | -- | -$0.58 | $0.10 | -$0.68 |
| 10/25/2022 | Q3 | -- | -- | $1.52 | $1.04 | $0.48 |
| 07/28/2022 | Q2 | -- | -- | $1.26 | $1.42 | -$0.16 |
| 05/02/2022 | Q1 | -- | -- | $1.43 | $0.91 | $0.52 |
| 02/10/2022 | Q4 | -- | -- | $1.39 | $0.88 | $0.51 |
| 11/04/2021 | Q3 | -- | -- | $1.27 | $1.02 | $0.25 |
| 07/29/2021 | Q2 | -- | -- | $0.39 | $0.94 | -$0.55 |
| 05/03/2021 | Q1 | -- | -- | $0.57 | $0.64 | -$0.07 |
| 02/11/2021 | Q4 | -- | -- | $0.11 | $0.41 | -$0.30 |
| 11/03/2020 | Q3 | -- | -- | $0.46 | $0.33 | $0.13 |
| 07/30/2020 | Q2 | -- | -- | $0.15 | $0.11 | $0.04 |
| 05/05/2020 | Q1 | -- | -- | $0.61 | $0.49 | $0.12 |
| 02/13/2020 | Q4 | -- | -- | -$1.92 | $0.45 | -$2.37 |
| 11/04/2019 | Q3 | -- | -- | $0.46 | $0.57 | -$0.11 |
| 08/01/2019 | Q2 | -- | -- | $0.57 | $0.90 | -$0.33 |
| 05/03/2019 | Q1 | -- | -- | $0.55 | $0.94 | -$0.39 |
| 02/14/2019 | Q4 | -- | -- | $0.83 | $1.03 | -$0.20 |
| 11/01/2018 | Q3 | -- | -- | $1.51 | -- | -- |
| 08/02/2018 | Q2 | -- | -- | $1.53 | -- | -- |
| 05/03/2018 | Q1 | -- | -- | $1.58 | -- | -- |
| 02/14/2018 | Q4 | -- | -- | $1.19 | -- | -- |
| 11/02/2017 | Q3 | -- | -- | $1.08 | -- | -- |
| 08/02/2017 | Q2 | -- | -- | $0.84 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | $0.79 | -- | -- |
| 02/15/2017 | Q4 | -- | -- | -$1.26 | -- | -- |
| 11/07/2016 | Q3 | -- | -- | $1.11 | -- | -- |
| 08/08/2016 | Q2 | -- | -- | -$0.10 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | $0.28 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$0.48 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$0.16 | -- | -- |
The Chemours Earnings Questions
-
How Much did The Chemours Generate in Revenue Last Quarter?
The Chemours reported $1.4B worth of top line sales in its most recent quarter.
-
Did The Chemours Beat Earnings Last Quarter?
The Chemours announced earnings per share of -$0.03 which represents a miss of analyst forecast a $0.20 per share.
-
Is The Chemours Profitable?
The Chemours reported $236M that represents $1.57 per share over the last quarter.
-
What is the Analyst Consensus for The Chemours EPS Next Year?
The Chemours's earnings are forecast to grow from $0.57 per share to $1.23 per share next year representing an increase of 189.44%.
-
When is The Chemours's Earnings Date?
The Chemours's next earnings date is August 1, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
